# BreezeBio

**Source:** https://www.startuphub.ai/startups/breezebio
**Profile type:** Startup

> BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

## About

BreezeBio, formerly GenEdit, is a biotechnology company focused on developing genetic medicines through targeted in vivo delivery. It utilizes its proprietary NanoGalaxy® platform, which consists of non-viral, non-lipid hydrophilic nanoparticles (HNPs). These nanoparticles are engineered to deliver various genetic payloads, including mRNA, siRNA, and gene editors, to specific cell types and tissues, such as immune cells, heart, lung, and central nervous system. The company is advancing an internal therapeutic pipeline with an initial focus on autoimmune diseases and oncology, with its lead candidate, BRZ-101, designed to restore immune tolerance in Type 1 diabetes. BreezeBio also engages in partnered programs to leverage its delivery technology.

## Key facts

- **Slug:** breezebio
- **Website:** https://breeze.bio/
- **Location:** Alameda, California, US
- **Founded:** 2016-01-01
- **Employees:** 63
- **Operating status:** Active
- **Total funding:** $94M
- **Sectors / tags:** Biotechnology, Genetic Medicine, Therapeutics, Drug Discovery
- **Social:**
  - LinkedIn: https://www.linkedin.com/company/breezebio/
  - Twitter: https://twitter.com/breezebio

## Frequently asked

### What does BreezeBio do?

BreezeBio, formerly GenEdit, is a biotechnology company focused on developing genetic medicines through targeted in vivo delivery. It utilizes its proprietary NanoGalaxy® platform, which consists of non-viral, non-lipid hydrophilic nanoparticles (HNPs). These nanoparticles are engineered to deliver various genetic payloads, including mRNA, siRNA, and gene editors, to specific cell types and tissues, such as immune cells, heart, lung, and central nervous system. The company is advancing an intern…

### What is BreezeBio's revenue?

StartupHub estimates BreezeBio's annual revenue at $7.9M (range $4.2M to $24.7M, 68% confidence), based on comparable companies in the sector.

### What is BreezeBio's valuation?

StartupHub estimates BreezeBio's effective valuation at $48.0M (range $22.3M to $72.7M, 55% confidence), based on comparable companies in the sector.

### How much funding has BreezeBio raised?

BreezeBio has raised a total of $94M in funding. The most recent round on record is Series B.

### Where is BreezeBio headquartered?

BreezeBio is headquartered in Alameda, California, US.

### When was BreezeBio founded?

BreezeBio was founded in 2016.

### What industry does BreezeBio operate in?

BreezeBio operates in Biotechnology, Genetic Medicine, Therapeutics, Drug Discovery.

### How many employees does BreezeBio have?

BreezeBio has approximately 63 people on record.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "BreezeBio",
          "item": "https://www.startuphub.ai/startups/breezebio"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/breezebio#webpage",
      "url": "https://www.startuphub.ai/startups/breezebio",
      "name": "BreezeBio - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of BreezeBio (formerly [\"GenEdit\"]). BreezeBio is a startup founded in 2016, operating in Biotechnology and Genetic Medicine. BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics. Headquartered in Alameda, California, US. The company has approximately 63 employees.",
      "dateModified": "2026-05-01T10:39:55.16296+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/breezebio#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/breezebio#organization",
      "name": "BreezeBio",
      "url": "https://breeze.bio/",
      "logo": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/startups/5d07d18f-c84c-4c6c-bc2c-6e5a96e069ab.jpg",
      "image": "https://cdn.startuphub.ai/storage/v1/object/public/entity-images/startups/5d07d18f-c84c-4c6c-bc2c-6e5a96e069ab.jpg",
      "description": "This is the official profile of BreezeBio (formerly [\"GenEdit\"]). BreezeBio is a startup founded in 2016, operating in Biotechnology and Genetic Medicine. BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics. Headquartered in Alameda, California, US. The company has approximately 63 employees.",
      "sameAs": [
        "https://www.linkedin.com/company/breezebio/",
        "https://twitter.com/breezebio",
        "https://www.startuphub.ai/startups/breezebio"
      ],
      "foundingDate": "2016-01-01",
      "numberOfEmployees": {
        "@type": "QuantitativeValue",
        "value": 63
      },
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Alameda",
        "addressRegion": "California",
        "addressCountry": "US"
      },
      "knowsAbout": [
        "Biotechnology",
        "Genetic Medicine",
        "Therapeutics",
        "Drug Discovery"
      ]
    }
  ]
}
```